Abstract
In this study, we assessed by a double-blinded, cross-over design the effect of intravenous and oral cisapride on esophageal motor activity during the late fed state in normal subjects. For the intravenous study, subjects were given placebo or 10 mg cisapride randomly, while in the oral study, they randomly received placebo or cisapride at 5, 10, or 20 mg. Cisapride given intravenously or orally caused a significant increase in resting LES pressure. The increase in LES pressure after oral administration was significant only after the 20 mg dose. Esophageal-body peristaltic amplitude, determined for all smooth-muscle sites, showed a modest but significant increase of approximately 10 mm Hg after intravenous cisapride, whereas no significant increase occurred after oral cisapride. Propagation time of peristalsis was unaffected by intravenous or oral cisapride. Side effects of treatment were minimal and at no time necessitated cessation of the study. We conclude that in healthy subjects during the late fed period, (1) cisapride at 10 mg intravenously or 20 mg orally increased resting LES pressure and (2) at 10 mg intravenously, but at no oral dose, cisapride increased peristaltic amplitude without affecting propagation time. The potentiating effect of cisapride on LES pressure suggests that cisapride could have an ancillary role in the therapy of gastroesophageal reflux disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Behar J, Brand DL, Brown FC, Castell DO, Cohen S, Crossley RS, Pope CE II, Winans CS: Cimetidine in the treatment of symptomatic gastroesophageal reflux: A double-blind controlled trial. Gastroenterology 74:441–448, 1978
Cohen S, Morris DW, Schoen HJ, DeMarino AJ: The effect of oral and intravenous metaclopramide on human lower esophageal sphincter pressure. Gastroenterology 79:484–487, 1976
McCallum RW, Ippoliti AF, Cooney C, Sturdevant RAL: A controlled trial of metaclopramide in symptomatic gastroesophageal reflux. N Engl J Med 296:354–357, 1977
Perkel MS, Kersh T, Moore L, Davidson ED: Metaclopramide therapy in fifty-five patients with delayed gastric emptying. Am J Gastroenterol 74:231–236, 1980
Bright-Asare P, El-Bassoussi M: Cimetidine, metaclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux. J Clin Gastroenterol 2:149–156, 1980
Albibi R, McCallum RW: Metaclopramide: Pharmacology and clinical application. Ann Intern Med 98:86–95, 1983
Grimes JD, Hassan MN, Preston DN: Adverse neurologic effects of metaclopramide. Can Med Assoc J 126:23–25, 1982
Corazziari E, Siopinaro F, Bontemeo I, Gatti V, Liberatore M, Biliotti D, Del Buono G, Vignoni D, Torsoli A: Effect of R 51619 on distal esophageal motor activity and gastric emptying. Ital J Gastroenterol 15:185–186, 1983
Lederer PL, Ellerman A, Ludwig S, Lux G: Effects of cisapride and metaclopramide on antroduodenal motor activity in man. Gastroenterology 88:1768, 1985
Reboa G, Arnulfo G, Di Somma C, Frascio M, Arzillo G, Berti-Riboli E, Lucchetti G: Prokinetic effects of cisapride on normal and antroduodenal motility and reflexes. Curr Ther Res 36:18–23, 1984
Reyntvens A, Verlinden M, De Coster R, Janisch HD, Smout D, De Creg J, Leempaels J, Verhaegen HS: Clinical pharmacological evidence for cisapride's lack of antidopiminergic or direct cholinergic properties. Curr Ther Res 36:1045–1052, 1984
Schuurkes JAJ, Verlinder M, Akkermans LMA, Van Nueten JM: Stimulating effects of cisapride on antroduodenal motility in the conscious dog.In Proceedings of the International Symposium on GI Motility, Aix-en-Provence. C. Roman (ed). MTP Press, 1984, pp 95–102
Wienbeck M, Cuder-Weisinger E, Berges W: Cisapride acts as a motor stimulator in the human esophagus. Gastroenterology 86:1298, 1984
Arndorfer RC, Steff JJ, Dodds WJ, Linehan JH, Hogan WS: Improved infusion system for intraluminal manometry. Gastroenterology 73:23–27, 1977
Collins BJ, Love AHG: The effect of chronic oral administration of cisapride on the 16-hour pH profile, esophageal transit and gastric emptying of patients with evidence of gastroesophageal reflux. Digestion 1986 (in press)
Smout ASPM, Bogard JW, Grade AL, Ten Thise Akkermans LMA, Wittebol P: Effects of cisapride, a new gastrointestinal prokinetic on intradigestive and postprandial motor activity of the distal esophagus of man. Gut 26:246–251, 1985
Gilbert RJ, Dodds, WJ: Effect of selective muscarinic antagonists on peristaltic contractions in esophageal smooth muscle. Am J Physiol 13:650–659, 1986
Dent J, Dodds WJ, Sekiguch T, Hogan WJ, Arndorfer RC: Interdigestive phasic contractions of the human lower esophageal sphincter. Gastroenterology 84:453–460, 1983
Holloway RH, Blank E, Takahashi I, Dodds WJ, Hogan WJ, Dent J: Variability of lower esophageal sphincter pressure in the fasted unanesthetized opossum. Am J Physiol 248:398–406, 1985
Itoh Z, Honda R, Aizawa I, Takeuchi S, Katsutoshi H, Couch E: Interdigestive motor activity of the lower esophageal sphincter in the conscious dog. Am J Dig Dis 23:239–247, 1978
Schuurkes JAJ, Van Jueten JM, Van Daele PGH, Reyntjens AJ, Janssen PAJ: Motor stimulating properties of cisapride on isolated gastrointestinal preparations in the guinea pig. J Pharmacol Exp Ther 234:775–783, 1984
Pfeuffer-Friederich I, Kilbinger H: Facilitation and inhibition by 5-hydroxytryptamine and R 51619 of acetylcholine release from guinea pig myenteric neurons.In Proceedings of the Ninth International Symposium on GI Motility, Aixen-Provence. C. Roman (ed) Lancaster, UK, MTP Press, 1984, pp 527–534
Nakyama S, Neya T, Yamasato T, Takaki M, Itanon. Effects of cisapride on the motility of digestive tract of dogs and guinea pigs. Jpn J Smooth Muscle Res 21:1–9, 1985
Van Neuten JM, Leysen JG, Niemegers CJE, Schuurkes JAJ: Cholinergic vs antidopaminergic properties of prokinetic substituted benzamides with GI prokinetic activity. Gastroenterology 88:1623, 1985
Dodds WJ, Dent J, Hogan WJ: Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 307:1547–1552, 1982
Stanciv C, Bennet JR: Esophageal acid clearing: One factor in the production of reflux esophagitis. Gut 15:852–857, 1974
McCallum RW, Berkowitz DM, Lerner E: Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 80:285–291, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilbert, R.J., Dodds, W.J., Kahrilas, P.J. et al. Effect of cisapride, a new prokinetic agent, on esophageal motor function. Digest Dis Sci 32, 1331–1336 (1987). https://doi.org/10.1007/BF01296657
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296657